Another experimental study in IL-1Ra-deficient mice implicated exaggerated IL-1β signaling in progression of CKD and anemia by showing that an antibody targeting IL-1β was able to ameliorate the kidney damage and improve the response to hypoxia (98). This evidence concerns the gene IL1B and Nephropathy.